Who makes EBV specific CTL Infusion?

EBV specific CTL Infusion is developed by Baylor College of Medicine.

What development phase is EBV specific CTL Infusion in?

EBV specific CTL Infusion is in Phase 1.

Last reviewed 2026-04-19 · How we verify

EBV specific CTL Infusion

Baylor College of Medicine · Phase 1 active Biologic

At a glance

Generic name	EBV specific CTL Infusion
Sponsor	Baylor College of Medicine
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

EBV specific CTL Infusion CI brief — competitive landscape report
EBV specific CTL Infusion updates RSS · CI watch RSS
Baylor College of Medicine portfolio CI